http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57114518-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a869d6fc950d50f6df03f549ca3afa
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1981-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410e0787ccaafec99337fbc60f4e28aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdcb1ffcb79bd57ed12352be1422b5d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa83fb54f33fd0785c4f8048ab0111c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89e6415e2151ab6579ac5f5cdafe9219
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66302d62999ec4b3d49d38b668939712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429c76a50ea86c84822206d32ea788d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6c05ec24e43eb12a13577b18626bcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5aa07bee1b2d76120c06f07eadb792
publicationDate 1982-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57114518-A
titleOfInvention Hypotensive agent
abstract PURPOSE: A safe hypotensive agent, containing aminobenzoic acid-N-D-mannoside or a salt thereof, usable continuously for a long term, having a high medicinal suitability and improved hypotensive action without exhibiting the mutagenicity. n CONSTITUTION: A hypotensive agent containing a compound of formulaIor a salt thereof as an active constituent. The compound of formulaIis used in an amount of 0.001W100wt% as an active constituent in the dosage form of powder or granule. The compound may assume any oral or parenteral administration form in use as an antidiabetic agent. In use for men and animals, the agent is preferably administered orally. The oral administration includes the sublingual administration. The daily dose per kg body weight for men is preferably 1W 400mg for the oral administration and 0.1W100mg for the parenteral administration in one W divided four fractions. The compound of formula II is particularly useful. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1981-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21324477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226780296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226780295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53960240

Total number of triples: 26.